These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8327848)

  • 21. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids.
    Marckmann P; Sandström B; Jespersen J
    Atherosclerosis; 1992 Oct; 96(2-3):235-44. PubMed ID: 1466654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
    Krysiak R; Okopień B; Herman Z
    Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
    Ossei-Gerning N; Wilson IJ; Grant PJ
    Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemostatic parameters related to lipids and adhesion molecules.
    Osterud B; Elvevoll EO; Brox J; Anderssen T; Eliassen LT; Halvorsen H; Høgmo P; Kvernmo H; Lia K; Lund T; Olsen JO; Olsen RL; Engstad CS; Vognild E
    Blood Coagul Fibrinolysis; 1999 Dec; 10(8):465-70. PubMed ID: 10636457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lipids and lipoproteins on thrombosis and rheology.
    Rosenson RS; Lowe GD
    Atherosclerosis; 1998 Oct; 140(2):271-80. PubMed ID: 9862270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris.
    Hankey CR; Lean ME; Lowe GD; Rumley A; Woodward M
    Eur J Clin Nutr; 2002 Oct; 56(10):1039-45. PubMed ID: 12373626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content.
    Marckmann P; Sandström B; Jespersen J
    Arterioscler Thromb; 1992 Feb; 12(2):201-5. PubMed ID: 1543694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
    Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state.
    Yildiz BO; Haznedaroğlu IC; Kirazli S; Bayraktar M
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3871-5. PubMed ID: 12161525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
    Humphries SE; Lane A; Dawson S; Green FR
    Arch Pathol Lab Med; 1992 Dec; 116(12):1322-9. PubMed ID: 1456879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.
    Sakr HF; Abbas AM; Haidara MA
    J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):61-71. PubMed ID: 29161233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women.
    Larsen LF; Andersen HR; Hansen AB; Andersen O
    Scand J Clin Lab Invest; 1996 May; 56(3):241-9. PubMed ID: 8761528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.